GlassScriptPhysician profile
Derek Paul Degrijs
NPI 1275893638
$14,690.55
in general payments reported to CMS, 2019-2025
31 companies · $1,326 in 2025
The $1,326 reported for 2025 was more than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,196 · 2020: $1,628 · 2021: $1,796 · 2022: $2,722 · 2023: $2,570 · 2024: $1,453 · 2025: $1,326.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,349.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,348.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $2,060.51 | 2019-2025 | General - Atherectomy, Eluvia, Peripheral Rotalink Plus |
| Silk Road Medical, INC. | $1,447.51 | 2019-2024 | Enroute Transcarotid Neuroprotection System, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter, Enroute Transcarotid Stent |
| Medtronic, INC. | $1,423.21 | 2021-2024 | Endurant Iis, Venaseal, Closurefast |
| Medtronic Vascular, INC. | $1,404.60 | 2019-2020 | |
| Inari Medical, INC. | $1,288.39 | 2020-2023 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Cardiovascular Systems INC. | $1,154.93 | 2019-2023 | Diamondback Peripheral |
| W. L. Gore & Associates, INC. | $881.28 | 2021-2024 | Excluder Conformable Aaa Endoprosthesis With Active Control, Gore Viabahn Endoprosthesis |
| Cook Medical LLC | $864.23 | 2019-2025 | Zilver Ptx, Lunderquist, Advance |
| Abbott Laboratories | $707.11 | 2020-2025 | Esprit, Jeti Peripheral Catheter |
| Bard Peripheral Vascular, INC. | $700.45 | 2021-2025 | Venovo, Venclose Maven Catheter, Rotarexs 6 F X 135 Cm |
| Shockwave Medical, INC | $664.27 | 2021-2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Intravascular Lithotripsy (Ivl) System With The Shockwave M5+ |
| Terumo Medical Corporation | $456.68 | 2021-2025 | Azur Cx Detachable, Hydropearl, Glidesheath Slender |
| Lemaitre Vascular, INC. | $222.63 | 2019-2025 | Artegraft Vascular Graft |
| Angiodynamics, INC. | $152.12 | 2025 | Auryon Laser System 100-120 Vac |
| Janssen Pharmaceuticals, INC | $151.56 | 2019-2024 | Xarelto |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $147.54 | 2025 | Artix Mt |
| Getinge USA Sales, LLC | $138.44 | 2019-2020 | |
| Bolton Medical INC | $130.76 | 2019 | |
| Becton, Dickinson and Company | $130.09 | 2021-2025 | Rotarexs 6 F X 135 Cm |
| Organogenesis INC. | $90.33 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $71.19 | 2022 | |
| Progenacare Global, LLC | $53.67 | 2023 | |
| Convatec INC. | $36.54 | 2025 | |
| Ekos Corporation | $28.76 | 2019 | |
| Ethicon US, LLC | $20.16 | 2020 | |
| Advanced Oxygen Therapy INC. | $20.00 | 2020 | |
| Cordis US Corp. | $19.38 | 2023 | Mynxgrip |
| E.R. Squibb & Sons, L.L.C. | $18.09 | 2025 | Eliquis |
| Abbvie INC. | $15.10 | 2021 | |
| Akcea Therapeutics, INC. | $13.90 | 2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $12.23 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Derek Degrijs listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.